Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 14, 2026 | HealthPartners | Infectious disease testing: gastroenterologyPayerPolicy · HEALTHPARTNERS-CC-ENTRY-282790 | New policy |
|---|
| May 14, 2026 | HealthPartners | Infectious disease testing: dermatologyPayerPolicy · HEALTHPARTNERS-CC-ENTRY-282390 | New policy |
|---|
| May 14, 2026 | HealthPartners | Inclisiran (Leqvio)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-248558 | New policy |
|---|
| May 14, 2026 | HealthPartners | Implanted and percutaneous peripheral nerve stimulation for treatment of painPayerPolicy · HEALTHPARTNERS-CC-ENTRY-232628 | New policy |
|---|
| May 14, 2026 | HealthPartners | Ibalizumab-uiyk (Trogarzo) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-204624 | New policy |
|---|
| May 14, 2026 | HealthPartners | Ibalizumab-uiyk (Trogarzo)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-202453 | New policy |
|---|
| May 14, 2026 | HealthPartners | IV iron replacement therapyPayerPolicy · HEALTHPARTNERS-CC-ENTRY-252172 | New policy |
|---|
| May 14, 2026 | HealthPartners | Hyperbaric oxygen therapyPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045963 | New policy |
|---|
| May 14, 2026 | HealthPartners | Hospital bedPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045960 | New policy |
|---|
| May 14, 2026 | HealthPartners | Home phototherapyPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045953 | New policy |
|---|
| May 14, 2026 | HealthPartners | Home health service benefits – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-287851 | New policy |
|---|
| May 14, 2026 | HealthPartners | Home health servicesPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045950 | New policy |
|---|
| May 14, 2026 | HealthPartners | Hereditary angioedema (HAE) drug therapy - Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-187825 | New policy |
|---|
| May 14, 2026 | HealthPartners | Hereditary angioedema (HAE) drug therapyPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045948 | New policy |
|---|
| May 14, 2026 | HealthPartners | Hematopoietic stem cell mobilizersPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046421 | New policy |
|---|
| May 14, 2026 | HealthPartners | Hemangioma treatmentPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045947 | New policy |
|---|
| May 14, 2026 | HealthPartners | Heart failure pressure sensor, implantable (i.e., CardioMEMS HF System)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-046438 | New policy |
|---|
| May 14, 2026 | HealthPartners | Health educationPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045940 | New policy |
|---|
| May 14, 2026 | HealthPartners | Habilitative therapiesPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046424 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gynecomastia surgeryPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046240 | New policy |
|---|
| May 14, 2026 | HealthPartners | Growth hormone drugs - WisconsinPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046308 | New policy |
|---|
| May 14, 2026 | HealthPartners | Golodirsen (Vyondys 53) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-226911 | New policy |
|---|
| May 14, 2026 | HealthPartners | Golodirsen (Vyondys 53)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-227158 | New policy |
|---|
| May 14, 2026 | HealthPartners | GnRH agonists for pubertal suppressionPayerPolicy · HEALTHPARTNERS-CC-ENTRY-197061 | New policy |
|---|
| May 14, 2026 | HealthPartners | Glucose testing supplies – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-223031 | New policy |
|---|
| May 14, 2026 | HealthPartners | Glucose testing suppliesPayerPolicy · HEALTHPARTNERS-CC-ENTRY-229035 | New policy |
|---|
| May 14, 2026 | HealthPartners | Givosiran (Givlaari) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-226837 | New policy |
|---|
| May 14, 2026 | HealthPartners | Givosiran (Givlaari)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-226973 | New policy |
|---|
| May 14, 2026 | HealthPartners | General approach to laboratory testingPayerPolicy · HEALTHPARTNERS-CC-ENTRY-232483 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for spinal muscular atrophy (Zolgensma, Ivitsma)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-214055 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for sickle cell disease (Casgevy, Lyfgenia)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-273523 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for recurrent respiratory papillomatosis: zopapogene imadenovec-drba (Papzimeos)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-287011 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for metachromatic leukodystrophy: atidarsagene autotemcel (Lenmeldy)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-278017 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for inherited retinal dystrophy (Luxturna)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-200362 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for hemophilia B (Hemgenix, Beqvez)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-257856 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for hemophilia A (Roctavian)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-267697 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for dystrophic epidermolysis bullosa (Vyjuvek, Zevaskyn)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-267698 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for cerebral adrenoleukodystrophy (Skysona)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-258169 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for beta-thalassemia (Casgevy, Zynteglo)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-258219 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for aromatic L-amino acid decarboxylase deficiency (Kebilidi)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-284475 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gene therapy for Duchenne muscular dystrophy - delandistrogene moxeparvovec-rokl (Elevidys)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-266926 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gender-affirming surgery – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-236032 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gender-affirming care, surgicalPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045928 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gender-affirming care, non-surgical – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-261229 | New policy |
|---|
| May 14, 2026 | HealthPartners | Gender-affirming care, non-surgicalPayerPolicy · HEALTHPARTNERS-CC-ENTRY-184234 | New policy |
|---|
| May 14, 2026 | HealthPartners | Fosdenopterin (Nulibry)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-235031 | New policy |
|---|
| May 14, 2026 | HealthPartners | Formula - amino acid based elemental - Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045923 | New policy |
|---|
| May 14, 2026 | HealthPartners | Foot carePayerPolicy · HEALTHPARTNERS-CC-AENTRY-045922 | New policy |
|---|
| May 14, 2026 | HealthPartners | Fluocinolone acetonide implants (Iluvien, Retisert and Yutiq)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-207224 | New policy |
|---|
| May 14, 2026 | HealthPartners | Filgrastim (Neupogen, Nivestym, Zarxio) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-228288 | New policy |
|---|